Find uplifting stories about heroes, innovations, and solutions
6788 results for "fda treatment"
The FDA is accelerating reviews of three psychedelic medications for depression and PTSD, moving promising mental health treatments closer to patients who desperately need them. Millions struggling with treatment-resistant conditions could soon have groundbreaking new options.
The FDA is accelerating breakthrough psychedelic therapies for treatment-resistant depression, PTSD, and alcohol use disorder after a presidential directive. Veterans and millions struggling with serious mental illness could gain access to promising new options backed by rigorous science.
A Minnesota company just won FDA approval for a breakthrough prostate cancer treatment that uses steam instead of surgery. The 30-minute outpatient procedure could help 84% of newly diagnosed patients avoid invasive treatments.
After surprising companies with a rejection in January, the FDA has agreed that existing trial data for a rare blood cancer therapy is sufficient for approval review. The agency's reversal gives new hope to patients with limited treatment options.
Patients with chronic lymphocytic leukemia now have a new treatment option that doesn't require chemotherapy and allows time off from treatment. The FDA approved the first all-oral, fixed-duration therapy for this common adult leukemia.
A new high dose version of an SMA treatment just won FDA approval, offering faster results for babies and children fighting this devastating muscle disease. The breakthrough gives families a more powerful option against a condition that once had no treatment at all.
Women with triple-negative breast cancer just gained two powerful new treatment options that work better than standard chemotherapy at keeping the disease under control. The FDA approved Trodelvy alone and combined with immunotherapy as first-line treatments for this aggressive cancer type.
The FDA just approved Optune Pax, a new treatment option for people battling locally advanced pancreatic cancer. This approval brings fresh hope to patients facing one of the most challenging cancer diagnoses.
A groundbreaking depression treatment using psilocybin is showing promising results in clinical trials, potentially becoming the first psychedelic therapy approved by the FDA. Two major studies confirm the compound helps patients with severe depression find relief.
The FDA just approved two new treatment combinations for cancer patients who've run out of options. These approvals bring fresh hope to people battling mantle cell lymphoma.
A promising new liver cancer treatment just received FDA Fast Track designation, potentially speeding up access for patients who need it most. The designation for PLT012 marks meaningful progress in the fight against one of the deadliest cancers.
Cancer patients gained several new FDA-approved tools this week, including tests to guide treatment decisions and drug combinations for hard-to-treat cancers. These advances offer fresh hope for more personalized, effective care.
After years without any approved therapies, adults living with chronic hepatitis delta virus now have hope with the FDA's approval of Hepcludex, the first treatment for one of the most severe forms of viral hepatitis. This breakthrough fills a critical gap for nearly 200,000 Americans who face rapid progression to serious liver complications.
The FDA is accelerating approval for psilocybin and MDMA-like therapies to treat depression and PTSD, potentially opening new doors for millions struggling with mental health conditions. Three companies are now on an expedited path to bring these promising treatments to patients who haven't found relief from traditional options.
A new targeted therapy for a rare form of lung cancer just earned priority review from the FDA, potentially offering hope to thousands of patients who currently have limited treatment options. The drug specifically targets HER2 mutations found in about 2-4% of lung cancer cases.
A newly approved ALS treatment can now target specific genetic causes of the disease, offering hope to patients with Lou Gehrig's disease. The FDA fast-tracked the therapy, marking a significant breakthrough in personalized medicine for neurological conditions.
Millions living with a painful, scarring skin disease may soon have hope for the first treatment designed specifically for their condition. The FDA just granted breakthrough status to a new drug that could change lives for people with cutaneous lupus.
A pharmaceutical company has submitted a groundbreaking treatment for Tourette syndrome that could become the first FDA-approved therapy specifically designed for the condition in over a decade. Thousands of families who've waited years for better options may soon have new hope.
A new, stronger version of the popular weight loss medication Wegovy just got FDA approval, giving more Americans access to potentially more effective obesity treatment. The approval came through a new fast-track program designed to speed up medicines that address major health priorities.
Pet owners in affected areas now have access to an affordable, fast-acting treatment that kills screwworm larvae within hours. The FDA's emergency authorization provides a crucial new tool as health officials work to contain the pest following recent U.S. detections.
Showing 20 of 6788